379 related articles for article (PubMed ID: 23821659)
1. Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia.
Ferrajoli A; Shanafelt TD; Ivan C; Shimizu M; Rabe KG; Nouraee N; Ikuo M; Ghosh AK; Lerner S; Rassenti LZ; Xiao L; Hu J; Reuben JM; Calin S; You MJ; Manning JT; Wierda WG; Estrov Z; O'Brien S; Kipps TJ; Keating MJ; Kay NE; Calin GA
Blood; 2013 Sep; 122(11):1891-9. PubMed ID: 23821659
[TBL] [Abstract][Full Text] [Related]
2. Association of elevated serumfree light chains with chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis.
Clay-Gilmour AI; Rishi AR; Goldin LR; Greenberg-Worisek AJ; Achenbach SJ; Rabe KG; Maurer MJ; Kay NE; Shanafelt TD; Call TG; Brice Weinberg J; Camp NJ; Cerhan JR; Leis J; Norman A; Murray DL; Vincent Rajkumar S; Caporaso NE; Landgren O; McMaster ML; Slager SL; Vachon CM
Blood Cancer J; 2019 Aug; 9(8):59. PubMed ID: 31383849
[TBL] [Abstract][Full Text] [Related]
3. Opposite Prognostic Significance of Cellular and Serum Circulating MicroRNA-150 in Patients with Chronic Lymphocytic Leukemia.
Stamatopoulos B; Van Damme M; Crompot E; Dessars B; Housni HE; Mineur P; Meuleman N; Bron D; Lagneaux L
Mol Med; 2015 Jan; 21(1):123-33. PubMed ID: 25584781
[TBL] [Abstract][Full Text] [Related]
4. Immunophenotypic and gene expression analysis of monoclonal B-cell lymphocytosis shows biologic characteristics associated with good prognosis CLL.
Lanasa MC; Allgood SD; Slager SL; Dave SS; Love C; Marti GE; Kay NE; Hanson CA; Rabe KG; Achenbach SJ; Goldin LR; Camp NJ; Goodman BK; Vachon CM; Spector LG; Rassenti LZ; Leis JF; Gockerman JP; Strom SS; Call TG; Glenn M; Cerhan JR; Levesque MC; Weinberg JB; Caporaso NE
Leukemia; 2011 Sep; 25(9):1459-66. PubMed ID: 21617698
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of DNA damage and alteration of the DNA damage response in monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia.
Popp HD; Flach J; Brendel S; Ruppenthal S; Kleiner H; Seifarth W; Schneider S; Schulze TJ; Weiss C; Wenz F; Hofmann WK; Fabarius A
Leuk Lymphoma; 2019 Mar; 60(3):795-804. PubMed ID: 30376743
[TBL] [Abstract][Full Text] [Related]
6. Chronic lymphocytic leukemia-like monoclonal B-cell lymphocytosis exhibits an increased inflammatory signature that is reduced in early-stage chronic lymphocytic leukemia.
Blanco G; Puiggros A; Sherry B; Nonell L; Calvo X; Puigdecanet E; Chiu PY; Kieso Y; Ferrer G; Palacios F; Arnal M; Rodríguez-Rivera M; Gimeno E; Abella E; Rai KR; Abrisqueta P; Bosch F; Calon A; Ferrer A; Chiorazzi N; Espinet B
Exp Hematol; 2021 Mar; 95():68-80. PubMed ID: 33421548
[TBL] [Abstract][Full Text] [Related]
7. Combined patterns of IGHV repertoire and cytogenetic/molecular alterations in monoclonal B lymphocytosis versus chronic lymphocytic leukemia.
Henriques A; Rodríguez-Caballero A; Nieto WG; Langerak AW; Criado I; Lécrevisse Q; González M; Pais ML; Paiva A; Almeida J; Orfao A
PLoS One; 2013; 8(7):e67751. PubMed ID: 23844084
[TBL] [Abstract][Full Text] [Related]
8. Reduced expansion of CD94/NKG2C
Puiggros A; Blanco G; Muntasell A; Rodríguez-Rivera M; Nonell L; Altadill M; Puigdecanet E; Arnal M; Calvo X; Gimeno E; Abella E; Abrisqueta P; Bosch F; Yélamos J; Ferrer A; López-Botet M; Espinet B
Int J Lab Hematol; 2021 Oct; 43(5):1032-1040. PubMed ID: 33615729
[TBL] [Abstract][Full Text] [Related]
9. Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia.
Shanafelt TD; Kay NE; Rabe KG; Call TG; Zent CS; Maddocks K; Jenkins G; Jelinek DF; Morice WG; Boysen J; Schwager S; Bowen D; Slager SL; Hanson CA
J Clin Oncol; 2009 Aug; 27(24):3959-63. PubMed ID: 19620484
[TBL] [Abstract][Full Text] [Related]
10. Polygenic risk score and risk of monoclonal B-cell lymphocytosis in caucasians and risk of chronic lymphocytic leukemia (CLL) in African Americans.
Kleinstern G; Weinberg JB; Parikh SA; Braggio E; Achenbach SJ; Robinson DP; Norman AD; Rabe KG; Boddicker NJ; Vachon CM; Lesnick CE; Call TG; Brander DM; Rassenti LZ; Kipps TJ; Olson JE; Cerhan JR; Kay NE; Furman RR; Hanson CA; Shanafelt TD; Slager SL
Leukemia; 2022 Jan; 36(1):119-125. PubMed ID: 34285341
[TBL] [Abstract][Full Text] [Related]
11. General population low-count CLL-like MBL persists over time without clinical progression, although carrying the same cytogenetic abnormalities of CLL.
Fazi C; Scarfò L; Pecciarini L; Cottini F; Dagklis A; Janus A; Talarico A; Scielzo C; Sala C; Toniolo D; Caligaris-Cappio F; Ghia P
Blood; 2011 Dec; 118(25):6618-25. PubMed ID: 21876118
[TBL] [Abstract][Full Text] [Related]
12. The immunoglobulin gene repertoire of low-count chronic lymphocytic leukemia (CLL)-like monoclonal B lymphocytosis is different from CLL: diagnostic implications for clinical monitoring.
Dagklis A; Fazi C; Sala C; Cantarelli V; Scielzo C; Massacane R; Toniolo D; Caligaris-Cappio F; Stamatopoulos K; Ghia P
Blood; 2009 Jul; 114(1):26-32. PubMed ID: 19029437
[TBL] [Abstract][Full Text] [Related]
13. Aberrant expression profile of miR-32, miR-98 and miR-374 in chronic lymphocytic leukemia.
Rahimi Z; Ghorbani Z; Motamed H; Jalilian N
Leuk Res; 2021 Dec; 111():106691. PubMed ID: 34455196
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal B-cell lymphocytosis: a reappraisal of its clinical implications.
Molica S; Mauro FR; Molica M; Del Giudice I; Foà R
Leuk Lymphoma; 2012 Sep; 53(9):1660-5. PubMed ID: 22335530
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia.
Rawstron AC; Bennett FL; O'Connor SJ; Kwok M; Fenton JA; Plummer M; de Tute R; Owen RG; Richards SJ; Jack AS; Hillmen P
N Engl J Med; 2008 Aug; 359(6):575-83. PubMed ID: 18687638
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal B-cell lymphocytosis in first-degree relatives of patients with sporadic (non-familial) chronic lymphocytic leukaemia.
Matos DM; Ismael SJ; Scrideli CA; de Oliveira FM; Rego EM; Falcão RP
Br J Haematol; 2009 Nov; 147(3):339-46. PubMed ID: 19709083
[TBL] [Abstract][Full Text] [Related]
17. Clinical aspects of monoclonal B-cell lymphocytosis.
Mowery YM; Lanasa MC
Cancer Control; 2012 Jan; 19(1):8-17. PubMed ID: 22143058
[TBL] [Abstract][Full Text] [Related]
18. Chronic lymphocytic leukaemia (CLL) and CLL-type monoclonal B-cell lymphocytosis (MBL) show differential expression of molecules involved in lymphoid tissue homing.
Rawstron AC; Shingles J; de Tute R; Bennett F; Jack AS; Hillmen P
Cytometry B Clin Cytom; 2010; 78 Suppl 1():S42-6. PubMed ID: 20839337
[TBL] [Abstract][Full Text] [Related]
19. B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome.
Shanafelt TD; Kay NE; Jenkins G; Call TG; Zent CS; Jelinek DF; Morice WG; Boysen J; Zakko L; Schwager S; Slager SL; Hanson CA
Blood; 2009 Apr; 113(18):4188-96. PubMed ID: 19015397
[TBL] [Abstract][Full Text] [Related]
20. Common occurrence of monoclonal B-cell lymphocytosis among members of high-risk CLL families.
Goldin LR; Lanasa MC; Slager SL; Cerhan JR; Vachon CM; Strom SS; Camp NJ; Spector LG; Leis JF; Morrison VA; Glenn M; Rabe KG; Achenbach SJ; Algood SD; Abbasi F; Fontaine L; Yau M; Rassenti LZ; Kay NE; Call TG; Hanson CA; Weinberg JB; Marti GE; Caporaso NE
Br J Haematol; 2010 Oct; 151(2):152-8. PubMed ID: 20738309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]